Document is current
Any future updates will be listed below
-
Authors
Yanagiya, Ryo https://orcid.org/0000-0002-2092-8194
Miyatake, Yuji
Watanabe, Natsumi
Shimizu, Takanobu
Kanamori, Akane
Ueno, Masaya https://orcid.org/0000-0001-9177-8640
Okabe, Sachiko
Carreras, Joaquim https://orcid.org/0000-0002-6129-8299
Nakayama, Shunya
Hasegawa, Ami
Kameda, Kazuaki
Kamakura, Takeshi
Nakagawa, So
Yamauchi, Takuji
Maeda, Takahiro https://orcid.org/0000-0003-4530-6460
Ishii, Keisuke
Matsuura, Tadashi
Handa, Hiroshi https://orcid.org/0000-0003-3753-9862
Hirao, Atsushi https://orcid.org/0000-0001-7818-8240
Ishizawa, Kenichi
Onizuka, Makoto
Mashima, Tetsuo
Nakamura, Naoya
Ando, Kiyoshi
Kotani, Ai https://orcid.org/0000-0002-0976-8687
-
Funding
Funding for this research was provided by:
MEXT | Japan Society for the Promotion of Science (JP23H02940, JP24K19229, JP23K14629, JP22H04922)
Japan Agency for Medical Research and Development (22ama221213h0002, 23ama221216h0002, 23fk0210133s0401)
MEXT | Japan Science and Technology Agency (JPMJCR19H5)
Tokai University Tokuda Memorial Cancer/Genome Basic Research Grant for Young Investigators
- License Information
-
More Information
Article History
Received: 14 January 2024
Revised: 15 May 2024
Accepted: 22 May 2024
First Online: 24 June 2024
Competing interests
: TM was a chief technology officer and an executive officer, and KI was a research manager of Perseus Proteomics Inc. Both has stock options. The authors do not have any other conflict of interest to be disclosed.
: The experiments using patient-derived materials were approved by the Institutional Review Board of Tokai University (H18-144) and performed in accordance with Declaration of Helsinki. Written informed consent was obtained from all subjects.
